View in EDS HTML Full Text PDF Full Text

Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects.

Saved in:
Bibliographic Details
Title: Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects.
Authors: Lim, Soo1 (AUTHOR) limsoo@snu.ac.kr, Sohn, Minji1 (AUTHOR), Shin, Yujin1 (AUTHOR), Ferrannini, Ele2 (AUTHOR) ferranni@ifc.cnr.it
Source: Diabetes, Obesity & Metabolism. Apr2022, Vol. 24 Issue 4, p757-762. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14628902
DOI:10.1111/dom.14627